Robert Serunjogi

发表

A hospital-based birth defects surveillance system in Kampala, Uganda

P. Musoke, D. Valencia, Daniel Mumpe-Mwanja, 2019, BMC Pregnancy and Childbirth.

Virologic response of treatment experienced HIV-infected Ugandan children and adolescents on NNRTI based first-line regimen, previously monitored without viral load

P. Musoke, M. Nannyonga, L. Barlow-Mosha, 2020, BMC Pediatrics.

Prevalence of neural tube defects, maternal HIV status, and antiretroviral therapy from a hospital-based birth defect surveillance in Kampala, Uganda

C. Moore, P. Musoke, L. Nelson, 2021, Birth defects research.

Overcoming staffing challenges when implementing a birth defects surveillance system: a Ugandan experience

M. Nolan, P. Musoke, D. Valencia, 2020, Journal of global health reports.

Catch-up growth and nutritional status of preterms born at a Ugandan tertiary hospital: An Observational study.

I. Munabi, Robert Serunjogi, S. Kiguli, 2020 .

Adverse Neonatal Birth Outcomes Among Adolescent Pregnancies in Kampala, Uganda Between 2015 –2018

P. Musoke, S. Tinker, D. Valencia, 2020 .

Mobile tablets for real-time data collection for hospital-based birth defects surveillance in Kampala, Uganda: Lessons learned

P. Musoke, D. Valencia, Daniel Mumpe-Mwanja, 2022, PLOS Global Public Health.

ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing

J. Seeley, C. Giaquinto, O. Kobusingye, 2021, BMC Infectious Diseases.

Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial

Ana C. Matos, C. Königs, C. Giaquinto, 2022, The lancet. HIV.

Comparative analysis of perinatal outcomes and birth defects amongst adolescent and older Ugandan mothers: evidence from a hospital-based surveillance database

P. Musoke, D. Valencia, Daniel Mumpe-Mwanja, 2021, Reproductive Health.

Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial

Ana C. Matos, C. Königs, J. Seeley, 2022, The lancet. HIV.